Skip to content
September 10, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Genomics and Precision Medicine
  • Beyond Automation: Pioneering the Future of Agentic AI and Scientific Discovery
  • Genomics and Precision Medicine

Beyond Automation: Pioneering the Future of Agentic AI and Scientific Discovery

Azzam Bilal Chamdy September 10, 2026 7 minutes read
beyond-automation-pioneering-the-future-of-agentic-ai-and-scientific-discovery

In the rapidly evolving landscape of artificial intelligence, a fundamental question has emerged: Can machines transcend the role of automated assistants to become active participants in the creative scientific process? This inquiry sits at the heart of an upcoming dual-session presentation featuring two of the field’s most prominent figures: Professor George Karniadakis and PhD candidate Nazanin Ahmadi.

Together, they will explore the convergence of Scientific Machine Learning (SciML) and agentic AI—a multidisciplinary frontier that promises to reshape how we formulate hypotheses, validate models, and uncover the fundamental laws governing complex systems.

The Symposium Schedule: A Morning of Innovation

The event is structured to provide both a theoretical foundation and a practical demonstration of these cutting-edge methodologies.

  • 9:00 a.m. – 9:45 a.m.: George Karniadakis (Brown University) will deliver an opening talk exploring the mathematical and physical underpinnings of agentic scientific discovery.
  • 10:00 a.m. – 10:50 a.m.: Nazanin Ahmadi (Brown University) will follow with a session detailing the practical implementation of these frameworks in systems biology and pharmacometrics.

The Convergence of Physics and Machine Learning

The core thesis of the presentation centers on the limitation of current AI models. While large language models and standard neural networks excel at pattern recognition, they often lack the "grounding" required for rigorous scientific discovery. Karniadakis and Ahmadi argue that true scientific creativity does not emerge in a vacuum; it is the product of a delicate interplay between data, mathematical structures, and physical laws.

Bridging the Gap: The SciML Framework

Scientific Machine Learning (SciML) serves as the engine for this new paradigm. By integrating physics-informed neural networks (PINNs) and neural operators, researchers can ensure that AI-generated models respect the conservation laws and physical constraints inherent in the natural world. Unlike "black-box" AI models that might produce statistically accurate but physically impossible results, SciML frameworks provide a bridge, ensuring that machine learning outputs are interpretable and scientifically valid.

The Agentic Turn

The speakers will introduce an "agentic framework" designed to mirror the collaborative nature of human research teams. Rather than relying on a single, monolithic model, this framework deploys a network of specialized agents. These agents are tasked with specific roles—proposing hypotheses, critiquing assumptions, running computational validations, and self-correcting through iterative feedback. This multi-agent approach mimics the social structure of a laboratory, where diverse perspectives are required to refine complex theories and identify genuine anomalies in data.

Biography: George Karniadakis

George Karniadakis is a titan in the field of computational mathematics. An elected member of the National Academy of Engineering and the National Academy of Arts and Sciences, his career reflects a lifelong dedication to pushing the boundaries of numerical analysis and fluid mechanics.

His academic journey, which includes advanced degrees from MIT and appointments at Princeton, Caltech, and Brown, is marked by an unparalleled citation record—over 184,000 citations and an h-index of 171. In 2025, he was recognized by Research.com as the preeminent mathematical scientist in the world. His accolades include the William Benter Prize, the SIAM/ACM Prize on Computational Science & Engineering, and the Alexander von Humboldt award, among others. As a Vannevar Bush Faculty Fellow, his work continues to set the standard for how physics-informed AI is applied to complex real-world challenges.

Biography: Nazanin Ahmadi

Representing the next generation of scientific leadership, Nazanin Ahmadi is a PhD candidate in Biomedical Engineering at Brown University. Her research is at the vanguard of applying agentic AI to systems biology and pharmacometric modeling.

Ahmadi has gained significant recognition for her pioneering work in utilizing PINNs to solve inverse problems in pharmacology. Her research bridges the gap between theoretical machine learning and actionable biomedical insights, focusing on the creation of "mechanistically grounded" AI. Her contributions have been acknowledged through several prestigious awards, including a win at the Machine Learning in Drug Discovery Symposium at the Broad Institute and a top-three finish in the ASCPT Student & Trainee Research Pitch Competition. As an active organizer of SciML symposia, she is not only contributing to the technical literature but is also actively shaping the community of researchers working at the intersection of AI and biology.

Supporting Data and Real-World Applications

The presentation will provide concrete evidence of these systems in action, moving beyond abstract theory to demonstrate utility in high-stakes environments.

Decoding Complex Systems

One of the key examples provided in the abstract is the application of these agentic frameworks to gene-expression trajectories. By integrating prior biological knowledge with high-dimensional data, the agents can identify non-obvious patterns in how genes regulate one another—patterns that traditional statistical methods often overlook.

Advancing Precision Medicine

In the realm of cancer-treatment dynamics, the ability to formulate and test hypotheses autonomously is revolutionary. Ahmadi’s work suggests that by using agentic AI, researchers can simulate the impact of various therapeutic interventions on patient-specific models. These agents can effectively "stress-test" treatment protocols, predicting potential resistance mechanisms before they appear in clinical settings. This capability represents a massive shift from the trial-and-error approach currently dominating many areas of pharmacology toward a model-driven, predictive future.

Implications for the Future of Scientific Research

The implications of this research are profound. If we can successfully offload the formulation and iterative testing of hypotheses to agentic AI, we may be on the cusp of a "discovery explosion."

Toward Autonomous Discovery

The ultimate goal of this research is not to replace human scientists, but to augment their capabilities. By automating the "drudgery" of hypothesis testing and validation, AI can free human researchers to focus on the high-level conceptual questions that define scientific breakthroughs. The framework proposed by Karniadakis and Ahmadi suggests that future scientific laboratories will function as hybrid environments, where human researchers define the goals and physical constraints, and a fleet of specialized agents executes the rigorous search for novel models.

Identifying the Unexplained

Perhaps most importantly, the speakers will address the potential for these systems to identify "unexplained patterns." In many fields, data is abundant, but the underlying mechanisms remain elusive. Agentic AI is uniquely positioned to traverse massive datasets, identifying anomalies that do not fit existing models and suggesting new, testable hypotheses to explain them. This could provide the necessary impetus to move scientific fields forward that have historically stalled due to the complexity of the data involved.

Conclusion: A New Era of Collaboration

The upcoming talks by George Karniadakis and Nazanin Ahmadi offer a rare glimpse into the future of scientific inquiry. By synthesizing physics-informed machine learning with multi-agent reasoning, they are providing the blueprint for a new generation of computational research.

As these technologies mature, the line between "computational tool" and "research partner" will continue to blur. The scientific community is currently at a turning point, moving away from purely descriptive data analysis toward a future of autonomous, interpretable, and truly creative discovery. Whether exploring the intricacies of gene expression or designing the next generation of life-saving therapeutics, the integration of agentic AI into the scientific workflow stands as one of the most promising frontiers of the 21st century.

For researchers, students, and practitioners interested in the convergence of AI and the natural sciences, these sessions offer an essential look at the methodologies that will define the next decade of discovery.

About the Author

Azzam Bilal Chamdy

Author

View All Posts

Post navigation

Previous: The Vital Intersection of Policy and Progress: Why ASHG Advocacy Matters for the Future of Human Genetics
Next: A New Frontier in Precision Oncology: FDA Grants Accelerated Approval to Etcamah (Camizestrant)

Related Stories

decoding-the-innate-frontier-the-scientific-journey-and-impact-of-marco-colonna
  • Genomics and Precision Medicine

Decoding the Innate Frontier: The Scientific Journey and Impact of Marco Colonna

Evan Lee Salim September 10, 2026
the-vital-intersection-of-policy-and-progress-why-ashg-advocacy-matters-for-the-future-of-human-genetics
  • Genomics and Precision Medicine

The Vital Intersection of Policy and Progress: Why ASHG Advocacy Matters for the Future of Human Genetics

Nana Muazin September 10, 2026
the-frontier-of-genetic-medicine-decoding-the-in-vivo-vs-ex-vivo-divide
  • Genomics and Precision Medicine

The Frontier of Genetic Medicine: Decoding the ‘In Vivo’ vs. ‘Ex Vivo’ Divide

Nila Kartika Wati September 10, 2026

Recent Posts

  • The Great Biotech Renaissance: How "Shells" Became Wall Street’s Hottest Asset
  • Rallying for Research: METAvivor Prepares for the 2026 Stage IV Stampede and Summit in Washington, D.C.
  • The Wisdom of the Skin: Revisiting B.K.S. Iyengar’s Philosophy on Breath and Asana
  • AI’s True Power in Breast Cancer Screening: Collaboration, Not Replacement, New Research Reveals
  • The Alchemy of Care: Redefining the Patient Experience in Oncology

Recent Comments

No comments to show.

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-great-biotech-renaissance-how-shells-became-wall-streets-hottest-asset
  • Chemotherapy and Targeted Therapy

The Great Biotech Renaissance: How "Shells" Became Wall Street’s Hottest Asset

Muslim September 10, 2026
rallying-for-research-metavivor-prepares-for-the-2026-stage-iv-stampede-and-summit-in-washington-d-c
  • Metastatic Breast Cancer Research

Rallying for Research: METAvivor Prepares for the 2026 Stage IV Stampede and Summit in Washington, D.C.

Raul Delapena Setiawan September 10, 2026
the-wisdom-of-the-skin-revisiting-b-k-s-iyengars-philosophy-on-breath-and-asana
  • Integrative Oncology and Holistic Care

The Wisdom of the Skin: Revisiting B.K.S. Iyengar’s Philosophy on Breath and Asana

Lina Irawan September 10, 2026
ais-true-power-in-breast-cancer-screening-collaboration-not-replacement-new-research-reveals
  • Medical Research and Clinical Trials

AI’s True Power in Breast Cancer Screening: Collaboration, Not Replacement, New Research Reveals

Dwi Wanna September 10, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.